Does the media prefer COR or CAH?

In the previous week, Cardinal Health had 18 more articles in the media than Cencora. MarketBeat recorded 49 mentions for Cardinal Health and 31 mentions for Cencora. Cencora's average media sentiment score of 1.35 beat Cardinal Health's score of 1.25 indicating that Cencora is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cencora 23 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Cardinal Health 31 Very Positive mention(s) 5 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer COR or ELV?

In the previous week, Elevance Health had 2 more articles in the media than Cencora. MarketBeat recorded 33 mentions for Elevance Health and 31 mentions for Cencora. Elevance Health's average media sentiment score of 1.64 beat Cencora's score of 1.35 indicating that Elevance Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cencora 23 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Elevance Health 31 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Which has better valuation and earnings, COR or MCK?

McKesson has higher revenue and earnings than Cencora. McKesson is trading at a lower price-to-earnings ratio than Cencora, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cencora $321.33B 0.19 $1.55B $13.46 23.54 McKesson $403.43B 0.24 $4.76B $37.37 22.68

Is COR or MCK more profitable?

McKesson has a net margin of 1.12% compared to Cencora's net margin of 0.79%. Cencora's return on equity of 125.45% beat McKesson's return on equity. Company Net Margins Return on Equity Return on Assets Cencora 0.79% 125.45% 4.18% McKesson 1.12% -253.21% 5.90%

Does the media favor COR or MCK?

In the previous week, McKesson had 14 more articles in the media than Cencora. MarketBeat recorded 45 mentions for McKesson and 31 mentions for Cencora. McKesson's average media sentiment score of 1.54 beat Cencora's score of 1.35 indicating that McKesson is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cencora 23 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive McKesson 40 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Very Positive

Which has higher valuation & earnings, HSIC or COR?

Cencora has higher revenue and earnings than Henry Schein. Cencora is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Henry Schein $13.60B 0.73 $398M $3.43 25.87 Cencora $321.33B 0.19 $1.55B $13.46 23.54

Is HSIC or COR more profitable?

Henry Schein has a net margin of 2.96% compared to Cencora's net margin of 0.79%. Cencora's return on equity of 125.45% beat Henry Schein's return on equity. Company Net Margins Return on Equity Return on Assets Henry Schein 2.96% 15.97% 5.56% Cencora 0.79% 125.45% 4.18%

Does the media refer more to HSIC or COR?

In the previous week, Cencora had 24 more articles in the media than Henry Schein. MarketBeat recorded 31 mentions for Cencora and 7 mentions for Henry Schein. Cencora's average media sentiment score of 1.35 beat Henry Schein's score of 0.95 indicating that Cencora is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Henry Schein 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cencora 23 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive

Which has preferable valuation and earnings, AHCO or COR?

Cencora has higher revenue and earnings than AdaptHealth. AdaptHealth is trading at a lower price-to-earnings ratio than Cencora, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio AdaptHealth $3.24B 0.23 -$70.79M -$1.71 N/A Cencora $321.33B 0.19 $1.55B $13.46 23.54

Is AHCO or COR more profitable?

Cencora has a net margin of 0.79% compared to AdaptHealth's net margin of -7.07%. Cencora's return on equity of 125.45% beat AdaptHealth's return on equity. Company Net Margins Return on Equity Return on Assets AdaptHealth -7.07% 3.36% 1.16% Cencora 0.79% 125.45% 4.18%

Does the media prefer AHCO or COR?

In the previous week, Cencora had 25 more articles in the media than AdaptHealth. MarketBeat recorded 31 mentions for Cencora and 6 mentions for AdaptHealth. Cencora's average media sentiment score of 1.35 beat AdaptHealth's score of 0.01 indicating that Cencora is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AdaptHealth 1 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Cencora 23 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive

Cencora (COR) Competitors

$316.80 -0.30 (-0.09%)

As of 11:59 AM Eastern

Compare

COR vs. CAH, ELV, MCK, HSIC, and AHCO

Should you buy Cencora stock or one of its competitors? Cencora's main competitors and comparable companies include Cardinal Health (CAH), Elevance Health (ELV), McKesson (MCK), Henry Schein (HSIC), and AdaptHealth (AHCO). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare providers & services" industry.

How does Cencora compare to Cardinal Health?

Cencora (NYSE:COR) and Cardinal Health (NYSE:CAH) are both large-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, media sentiment, institutional ownership, valuation, profitability and risk.

In the previous week, Cardinal Health had 18 more articles in the media than Cencora. MarketBeat recorded 49 mentions for Cardinal Health and 31 mentions for Cencora. Cencora's average media sentiment score of 1.35 beat Cardinal Health's score of 1.25 indicating that Cencora is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cencora	23 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
Cardinal Health	31 Very Positive mention(s)	5 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Cencora has a net margin of 0.79% compared to Cardinal Health's net margin of 0.67%. Cencora's return on equity of 125.45% beat Cardinal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cencora	0.79%	125.45%	4.18%
Cardinal Health	0.67%	-98.53%	4.69%

Cardinal Health has lower revenue, but higher earnings than Cencora. Cencora is trading at a lower price-to-earnings ratio than Cardinal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cencora	$321.33B	0.19	$1.55B	$13.46	23.54
Cardinal Health	$254.25B	0.21	$1.71B	$7.23	32.02

Cencora has a beta of 0.57, indicating that its share price is 43% less volatile than the broader market. Comparatively, Cardinal Health has a beta of 0.49, indicating that its share price is 51% less volatile than the broader market.

Cencora presently has a consensus price target of $370.85, suggesting a potential upside of 17.06%. Cardinal Health has a consensus price target of $266.56, suggesting a potential upside of 15.15%. Given Cencora's higher possible upside, equities research analysts clearly believe Cencora is more favorable than Cardinal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cencora	0 Sell rating(s)	3 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.81
Cardinal Health	0 Sell rating(s)	3 Hold rating(s)	16 Buy rating(s)	0 Strong Buy rating(s)	2.84

Cencora pays an annual dividend of $2.40 per share and has a dividend yield of 0.8%. Cardinal Health pays an annual dividend of $2.06 per share and has a dividend yield of 0.9%. Cencora pays out 17.8% of its earnings in the form of a dividend. Cardinal Health pays out 28.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cencora has raised its dividend for 15 consecutive years and Cardinal Health has raised its dividend for 29 consecutive years. Cardinal Health is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

97.5% of Cencora shares are owned by institutional investors. Comparatively, 87.2% of Cardinal Health shares are owned by institutional investors. 0.4% of Cencora shares are owned by company insiders. Comparatively, 0.1% of Cardinal Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Cencora beats Cardinal Health on 10 of the 19 factors compared between the two stocks.

How does Cencora compare to Elevance Health?

Cencora (NYSE:COR) and Elevance Health (NYSE:ELV) are both large-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, institutional ownership, earnings, profitability, analyst recommendations, dividends, valuation and risk.

Cencora pays an annual dividend of $2.40 per share and has a dividend yield of 0.8%. Elevance Health pays an annual dividend of $6.88 per share and has a dividend yield of 1.7%. Cencora pays out 17.8% of its earnings in the form of a dividend. Elevance Health pays out 30.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cencora has increased its dividend for 15 consecutive years and Elevance Health has increased its dividend for 14 consecutive years.

97.5% of Cencora shares are held by institutional investors. Comparatively, 89.2% of Elevance Health shares are held by institutional investors. 0.4% of Cencora shares are held by insiders. Comparatively, 0.3% of Elevance Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Elevance Health has a net margin of 2.47% compared to Cencora's net margin of 0.79%. Cencora's return on equity of 125.45% beat Elevance Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cencora	0.79%	125.45%	4.18%
Elevance Health	2.47%	14.64%	5.22%

Cencora presently has a consensus price target of $370.85, indicating a potential upside of 17.06%. Elevance Health has a consensus price target of $440.90, indicating a potential upside of 11.04%. Given Cencora's stronger consensus rating and higher probable upside, analysts clearly believe Cencora is more favorable than Elevance Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cencora	0 Sell rating(s)	3 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.81
Elevance Health	0 Sell rating(s)	8 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	2.65

Elevance Health has lower revenue, but higher earnings than Cencora. Elevance Health is trading at a lower price-to-earnings ratio than Cencora, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cencora	$321.33B	0.19	$1.55B	$13.46	23.54
Elevance Health	$199.13B	0.43	$5.66B	$22.50	17.65

Cencora has a beta of 0.57, meaning that its share price is 43% less volatile than the broader market. Comparatively, Elevance Health has a beta of 0.68, meaning that its share price is 32% less volatile than the broader market.

In the previous week, Elevance Health had 2 more articles in the media than Cencora. MarketBeat recorded 33 mentions for Elevance Health and 31 mentions for Cencora. Elevance Health's average media sentiment score of 1.64 beat Cencora's score of 1.35 indicating that Elevance Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cencora	23 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
Elevance Health	31 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

Elevance Health beats Cencora on 10 of the 19 factors compared between the two stocks.

How does Cencora compare to McKesson?

Cencora (NYSE:COR) and McKesson (NYSE:MCK) are both large-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, media sentiment, profitability, earnings and valuation.

McKesson has a net margin of 1.12% compared to Cencora's net margin of 0.79%. Cencora's return on equity of 125.45% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cencora	0.79%	125.45%	4.18%
McKesson	1.12%	-253.21%	5.90%

In the previous week, McKesson had 14 more articles in the media than Cencora. MarketBeat recorded 45 mentions for McKesson and 31 mentions for Cencora. McKesson's average media sentiment score of 1.54 beat Cencora's score of 1.35 indicating that McKesson is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cencora	23 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
McKesson	40 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Cencora has a beta of 0.57, meaning that its share price is 43% less volatile than the broader market. Comparatively, McKesson has a beta of 0.3, meaning that its share price is 70% less volatile than the broader market.

Cencora presently has a consensus target price of $370.85, indicating a potential upside of 17.06%. McKesson has a consensus target price of $973.44, indicating a potential upside of 14.87%. Given Cencora's stronger consensus rating and higher possible upside, equities analysts plainly believe Cencora is more favorable than McKesson.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cencora	0 Sell rating(s)	3 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.81
McKesson	0 Sell rating(s)	4 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.78

McKesson has higher revenue and earnings than Cencora. McKesson is trading at a lower price-to-earnings ratio than Cencora, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cencora	$321.33B	0.19	$1.55B	$13.46	23.54
McKesson	$403.43B	0.24	$4.76B	$37.37	22.68

97.5% of Cencora shares are owned by institutional investors. Comparatively, 85.1% of McKesson shares are owned by institutional investors. 0.4% of Cencora shares are owned by insiders. Comparatively, 0.1% of McKesson shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Cencora pays an annual dividend of $2.40 per share and has a dividend yield of 0.8%. McKesson pays an annual dividend of $3.28 per share and has a dividend yield of 0.4%. Cencora pays out 17.8% of its earnings in the form of a dividend. McKesson pays out 8.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cencora has increased its dividend for 15 consecutive years and McKesson has increased its dividend for 17 consecutive years.

Summary

McKesson beats Cencora on 11 of the 19 factors compared between the two stocks.

How does Cencora compare to Henry Schein?

Henry Schein (NASDAQ:HSIC) and Cencora (NYSE:COR) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, media sentiment, profitability, valuation, analyst recommendations, institutional ownership, earnings and risk.

Cencora has higher revenue and earnings than Henry Schein. Cencora is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Henry Schein	$13.60B	0.73	$398M	$3.43	25.87
Cencora	$321.33B	0.19	$1.55B	$13.46	23.54

Henry Schein currently has a consensus target price of $92.93, suggesting a potential upside of 4.75%. Cencora has a consensus target price of $370.85, suggesting a potential upside of 17.06%. Given Cencora's stronger consensus rating and higher probable upside, analysts clearly believe Cencora is more favorable than Henry Schein.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Henry Schein	1 Sell rating(s)	6 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.47
Cencora	0 Sell rating(s)	3 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.81

96.6% of Henry Schein shares are held by institutional investors. Comparatively, 97.5% of Cencora shares are held by institutional investors. 0.9% of Henry Schein shares are held by insiders. Comparatively, 0.4% of Cencora shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Cencora had 24 more articles in the media than Henry Schein. MarketBeat recorded 31 mentions for Cencora and 7 mentions for Henry Schein. Cencora's average media sentiment score of 1.35 beat Henry Schein's score of 0.95 indicating that Cencora is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Henry Schein	5 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cencora	23 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

Henry Schein has a beta of 0.8, indicating that its share price is 20% less volatile than the broader market. Comparatively, Cencora has a beta of 0.57, indicating that its share price is 43% less volatile than the broader market.

Henry Schein has a net margin of 2.96% compared to Cencora's net margin of 0.79%. Cencora's return on equity of 125.45% beat Henry Schein's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Henry Schein	2.96%	15.97%	5.56%
Cencora	0.79%	125.45%	4.18%

Summary

Cencora beats Henry Schein on 10 of the 16 factors compared between the two stocks.

How does Cencora compare to AdaptHealth?

AdaptHealth (NASDAQ:AHCO) and Cencora (NYSE:COR) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, dividends, profitability, analyst recommendations, institutional ownership, media sentiment, risk and valuation.

AdaptHealth presently has a consensus target price of $10.29, indicating a potential upside of 86.67%. Cencora has a consensus target price of $370.85, indicating a potential upside of 17.06%. Given AdaptHealth's higher probable upside, research analysts plainly believe AdaptHealth is more favorable than Cencora.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AdaptHealth	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.67
Cencora	0 Sell rating(s)	3 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.81

In the previous week, Cencora had 25 more articles in the media than AdaptHealth. MarketBeat recorded 31 mentions for Cencora and 6 mentions for AdaptHealth. Cencora's average media sentiment score of 1.35 beat AdaptHealth's score of 0.01 indicating that Cencora is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AdaptHealth	1 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cencora	23 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

Cencora has higher revenue and earnings than AdaptHealth. AdaptHealth is trading at a lower price-to-earnings ratio than Cencora, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AdaptHealth	$3.24B	0.23	-$70.79M	-$1.71	N/A
Cencora	$321.33B	0.19	$1.55B	$13.46	23.54

AdaptHealth has a beta of 1.47, indicating that its stock price is 47% more volatile than the broader market. Comparatively, Cencora has a beta of 0.57, indicating that its stock price is 43% less volatile than the broader market.

Cencora has a net margin of 0.79% compared to AdaptHealth's net margin of -7.07%. Cencora's return on equity of 125.45% beat AdaptHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AdaptHealth	-7.07%	3.36%	1.16%
Cencora	0.79%	125.45%	4.18%

82.7% of AdaptHealth shares are held by institutional investors. Comparatively, 97.5% of Cencora shares are held by institutional investors. 2.0% of AdaptHealth shares are held by company insiders. Comparatively, 0.4% of Cencora shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Cencora beats AdaptHealth on 12 of the 16 factors compared between the two stocks.

Get Cencora News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding COR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

COR vs. The Competition

Export

Metric	Cencora	Healthcare Providers & Services Industry	Healthcare Sector	NYSE Exchange
Market Cap	$60.45B	$9.77B	$7.30B	$24.19B
Dividend Yield	0.76%	2.54%	2.55%	3.72%
P/E Ratio	23.54	35.52	269.19	30.08
Price / Sales	0.19	4.94	623.49	20.09
Price / Cash	14.63	126.93	78.23	31.97
Price / Book	18.67	4.00	13.07	6.85
Net Income	$1.55B	$311.06M	$3.46B	$1.07B
7 Day Performance	2.15%	-0.09%	1.61%	-1.05%
1 Month Performance	4.33%	0.36%	4.76%	2.47%
1 Year Performance	4.46%	17.22%	27.96%	17.62%

Cencora Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
COR Cencora	4.9394 of 5 stars	$316.80 -0.1%	$370.85 +17.1%	+7.5%	$60.45B	$321.33B	23.54	51,000	Positive News Analyst Forecast
CAH Cardinal Health	4.8563 of 5 stars	$237.24 +0.4%	$251.73 +6.1%	+57.5%	$55.59B	$250.74B	36.29	57,700	Trending News Analyst Forecast Insider Trade
ELV Elevance Health	4.9175 of 5 stars	$395.67 +0.4%	$440.90 +11.4%	+27.6%	$85.86B	$199.13B	17.60	97,100	Positive News
MCK McKesson	4.93 of 5 stars	$876.42 +0.8%	$968.93 +10.6%	+26.1%	$102.17B	$403.43B	23.45	43,000	Positive News Analyst Forecast
HSIC Henry Schein	2.9218 of 5 stars	$88.15 +0.0%	$92.27 +4.7%	+30.7%	$9.83B	$13.18B	25.71	25,000	Analyst Upgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:COR) was last updated on 8/20/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cencora (COR) Competitors

COR vs. CAH, ELV, MCK, HSIC, and AHCO

How does Cencora compare to Cardinal Health?

Summary

How does Cencora compare to Elevance Health?

Summary

How does Cencora compare to McKesson?

Summary

How does Cencora compare to Henry Schein?

Summary

How does Cencora compare to AdaptHealth?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

COR vs. The Competition

Cencora Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cencora (COR) Competitors

COR vs. CAH, ELV, MCK, HSIC, and AHCO

How does Cencora compare to Cardinal Health?

Does the media prefer COR or CAH?

Is COR or CAH more profitable?

Which has preferable earnings & valuation, COR or CAH?

Which has more volatility & risk, COR or CAH?

Do analysts recommend COR or CAH?

Is COR or CAH a better dividend stock?

Do institutionals and insiders hold more shares of COR or CAH?

Summary

How does Cencora compare to Elevance Health?

Is COR or ELV a better dividend stock?

Do insiders and institutionals have more ownership in COR or ELV?

Is COR or ELV more profitable?

Do analysts rate COR or ELV?

Which has better valuation & earnings, COR or ELV?

Which has more volatility and risk, COR or ELV?

Does the media prefer COR or ELV?

Summary

How does Cencora compare to McKesson?

Is COR or MCK more profitable?

Does the media favor COR or MCK?

Which has more volatility & risk, COR or MCK?

Do analysts rate COR or MCK?

Which has better valuation and earnings, COR or MCK?

Do insiders and institutionals hold more shares of COR or MCK?

Is COR or MCK a better dividend stock?

Summary

How does Cencora compare to Henry Schein?

Which has higher valuation & earnings, HSIC or COR?

Do analysts rate HSIC or COR?

Do insiders and institutionals hold more shares of HSIC or COR?

Does the media refer more to HSIC or COR?

Which has more volatility and risk, HSIC or COR?

Is HSIC or COR more profitable?

Summary

How does Cencora compare to AdaptHealth?

Do analysts rate AHCO or COR?

Does the media prefer AHCO or COR?

Which has preferable valuation and earnings, AHCO or COR?

Which has more volatility & risk, AHCO or COR?

Is AHCO or COR more profitable?

Do insiders & institutionals believe in AHCO or COR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

COR vs. The Competition

Cencora Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools